Adams' new campaign HQ opens in SL Green building amid key support from real estate giant
Marc Holliday, SL Green's CEO, is a longtime supporter of Adams and offers him a crucial toehold into New York's influential — and wealthy — real estate sector. During the Democratic mayoral primary campaign, Adams' rival Andrew Cuomo courted most sections of the real estate world for financial support, including Holliday.
But with Cuomo's Democratic mayoral primary loss in the rearview, Holliday appears to be lining up squarely behind Adams, who's running on an independent line in November's general election.
Last week, Holliday hosted a fundraiser for Adams at One Madison, SL Green's flagship Flatiron District skyscraper, where hundreds of supporters donated nearly $1 million to the mayor. The massive haul comes as Adams is scrambling to mount an independent run against socialist Zohran Mamdani, the Democratic mayoral nominee who's the favorite to win in November, and Cuomo, who said Monday he is also staying in the race on an independent line.
Eighteen blocks north from One Madison, Adams has struck up another connection to SL Green, opening his campaign's new headquarters last week at the Graybar Building on Lexington Ave., one of a number of commercial properties the company owns in New York.
A source familiar with the matter told the Daily News that Adams' campaign is paying SL Green $55 per square foot in monthly rent for the space at Graybar. SL Green typically markets space in the building between $58 and $72 a square foot, according to real estate listings.
It wasn't immediately clear how much space the campaign is renting. Frank Carone, Adams' campaign chairman who's also a consultant working on SL Green's bid to build a casino in Manhattan, would only say the mayor's team is paying 'market rate' for the space.
SL Green, which holds extensive business interests before Adams' administration, didn't comment.
After Adams' September 2024 indictment on corruption charges, Holliday turned to Cuomo, pumping $100,000 into a super PAC that boosted the ex-governor's primary run. Cuomo is planning to run in the November election on an independent ballot line and is likely to try to seek support from the real estate and finance sectors that supported him during the primary.
But the new campaign headquarters and last week's large fundraiser indicate Adams has been able to tap at least portions of the deep-pocketed real estate industry for support, even as polling shows the mayor is facing an uphill climb amid continued fallout from his corruption indictment.
In turning to Holliday and SL Green for support, Adams is treading familiar ground.
Holliday is a longtime donor to Adams going back to the mayor's days as Brooklyn borough president. He and other SL Green executives have given nearly $30,000 to Adams' 2025 campaign, records show.
In addition to Wednesday's confab, Holliday hosted a fundraiser for Adams' reelection campaign at One Madison in July 2024 — two months before the mayor was indicted on bribery and campaign finance fraud charges — that raked in more than $100,000, per records obtained by The News via a Freedom of Information Law request.
Holliday and other SL Green execs are in the city's Doing Business database because of the various financial interests they have before city government.
One of SL Green's biggest current projects is its proposal to build a casino in Times Square. The state is expected later this year to select which developer will get to build a casino in the city, a highly coveted, lucrative business venture that the mayor is expected to have some input in.
Carone, Adams' ex-chief of staff and political confidant, has been helping SL Green with 'community engagement' on the casino bid since leaving City Hall in late 2022.
Citing the various overlapping political and business interests between the two sides, John Kaehny, a veteran government watchdog who runs the Reinvent Albany organization, called the Adams campaign's lease for its new headquarters 'sleazy,' arguing it opens the door to potential ethics issues, given Adams' campaign is effectively benefiting a big donor in renting the space.
Adams' campaign first revealed it would be using space in the Graybar Building last week when it also announced the mayor's new campaign team.
'We are ready to outorganize, outmessage, and outwork anyone standing in our way,' Carone said in a press release.
_____
New York Daily News reporter Josephine Stratman contributed to this story.)
_____
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
28 minutes ago
- Yahoo
Cardinal Health expands urology focus with $1.9bn Solaris Health deal
US drug distributor Cardinal Health has signed a $1.9bn agreement to acquire a majority stake in Solaris Health from Lee Equity Partners. The deal aims to expand the Specialty Alliance, the distributor's multi-speciality management services organisation (MSO) platform, in which Cardinal will gain a stake of around 75%. The acquisition will also create the Urology Alliance, comprising a collaborative network of urology providers within Cardinal's Specialty Alliance MSO, as well as resonate with plans to expand the delivery of urological patient care. Cardinal's Solaris buyout complements its recent acquisitions of Urology America, Potomac Urology, and Academic Urology & Urogynaecology, signalling its urologic strategy. The transaction is expected to be completed by the end of this year, pending customary closing conditions. Cardinal Health CEO Jason Hollar stated that growing the Speciality Alliance is a 'top priority' for the company, with the latest urology purchase leaving it 'well-positioned to meet the comprehensive needs of community urologists through the robust combined capabilities of the Specialty Alliance, Specialty Networks and Cardinal Health'. Research indicates there is a shortage of urologists in the US, with 62% of US counties lacking a practising urologist and just one new urologist entering the field for every ten retiring. The figures lead to challenges in the broader field, including delayed diagnoses, increased rates of advanced-stage conditions, and significant health disparities, with these particularly pronounced in rural communities. GlobalData's senior medical analyst Selena Yu foresees Cardinal's acquisition as reflecting a shift from drug distribution with a 'lower profit margin, towards higher margin speciality care in urology'. Yu said: 'MSOs help streamline backend work like billing and staffing to allow for physicians to focus on care. 'Additionally, with a large network of specialists, patients can receive care in the same region by different care specialists, which will reduce wait times and improve care continuity. Additionally, the Cardinal Health Alliance has other specialities like oncology specialists, which makes referrals more streamlined.' Cardinal's acquisition coincided with the release of its Q4 2025 financials. The company's profits per share came in at $2.08, beating the forecasted $2.03, yet profits for the quarter came in at $60.2bn, below the $60.92bn forecast, prompting a pre-market stock drop of more than 11% on 12 August. Cardinal's share price has since recovered to a drop of around 6% to $147.05 per share, down from $157.66 per share at market close on 11 August. "Cardinal Health expands urology focus with $1.9bn Solaris Health deal" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Effettua l'accesso per consultare il tuo portafoglio
Yahoo
28 minutes ago
- Yahoo
Texas sues Eli Lilly for allegedly bribing providers to prescribe its medications
WASHINGTON (Reuters) -Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly for allegedly "bribing" providers to prescribe its medications. The attorney general's office said in a statement that the company bribed and illegally induced medical providers to prescribe its most profitable drugs, including the GLP-1 medications Mounjaro and Zepbound, used for weight loss and diabetes treatment. "Big Pharma compromised medical decision-making by engaging in an illegal kickback scheme," Attorney General Paxton said. The lawsuit builds upon Attorney General's previous legal action to hold drug manufacturers accountable for fraud and abuse, the statement added. Last year, Paxton had sued insulin manufacturers, including Lilly and pharmacy benefit managers (PBMs), alleging that manufacturers artificially raised the prices of insulin and then paid a significant, undisclosed portion back to the PBMs for preferential treatment in return. Eli Lilly did not immediately respond to a Reuters request for comment. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Yahoo
28 minutes ago
- Yahoo
US Equity Indexes Jump After July Inflation Boosts Fed Rate-Cut Expectations
US equity indexes jumped in midday trading Tuesday, with the Nasdaq Composite and S&P 500 hitting al